venlafaxine hydrochloride has been researched along with Menopause in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (5.26) | 18.2507 |
| 2000's | 6 (31.58) | 29.6817 |
| 2010's | 11 (57.89) | 24.3611 |
| 2020's | 1 (5.26) | 2.80 |
| Authors | Studies |
|---|---|
| Crandall, CJ; Manson, JE; Mehta, JM | 1 |
| Anderson, GL; Carpenter, JS; Ensrud, KE; Freeman, EW; Guthrie, KA; Joffe, H; LaCroix, AZ; Larson, JC; Manson, JE; McCurry, SM; Morin, CM; Newton, KM; Otte, J; Reed, SD | 1 |
| Bates, C; Burns, RB; Reynolds, EE; Richardson, M | 1 |
| Deffenbacher, B; Lyon, C; Mullen, R; Nashelsky, J; Reed, A | 1 |
| Anderson, GL; Caan, B; Carpenter, JS; Cohen, LS; Ensrud, KE; Freeman, EW; Guthrie, KA; Joffe, H; Kroenke, K; Lacroix, AZ; Larson, JC; Newton, KM; Reed, SD; Sammel, MD; Sherman, S; Sternfeld, B | 1 |
| Holland, PJ; Keller, MB; Kornstein, SG; Nemeroff, CB; Ninan, PT; Pedersen, RD; Rothschild, AJ; Thase, ME; Trivedi, MH | 1 |
| Handley, AP; Williams, M | 1 |
| Caan, B; Carpenter, JS; Ensrud, KE; Freeman, EW; Guthrie, KA; Hohensee, C; Joffe, H; LaCroix, AZ; Landis, CA; Manson, J; Newton, KM; Otte, J; Reed, SD; Shifren, JL; Sternfeld, B; Woods, NF | 1 |
| Huang, S; Liu, C; Liu, X; Ye, Y | 1 |
| Bradley, R; Dillon, JE; Khalid, Z; Osuagwu, FC; Roy, N; Shah, B | 1 |
| Crider, M; Hill, DA; Hill, SR | 1 |
| Barton, DL | 1 |
| Doherty, DA; Emery, LI; Gregson, J; Hickey, M; Saunders, CM | 1 |
| Barton, D; Loprinzi, CL | 1 |
| Barton, D; Bearden, JD; Dakhil, SR; Fitch, TR; Kugler, JW; Levitt, R; Loprinzi, CL; Mailliard, JA; Nikcevich, DA; Sloan, JA; Tschetter, LK | 1 |
| Albertazzi, P | 1 |
| Amsterdam, JD; Garcia-España, F; Goodman, D; Hooper, M; Hornig-Rohan, M | 1 |
| Gottlieb, N | 1 |
| Grady-Weliky, TA; Hartmann, DM | 1 |
6 review(s) available for venlafaxine hydrochloride and Menopause
| Article | Year |
|---|---|
Management of Menopausal Symptoms: A Review.
Topics: Autonomic Nervous System Diseases; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Female Urogenital Diseases; Hot Flashes; Humans; Medroxyprogesterone Acetate; Menopause; Neoplasms; Paroxetine; Sweating; Venlafaxine Hydrochloride; Venous Thromboembolism | 2023 |
Clinical Inquiries: Does exercise relieve vasomotor menopausal symptoms?
Topics: Aged; Antidepressive Agents, Second-Generation; Citalopram; Estrogen Replacement Therapy; Exercise Therapy; Fatty Acids, Omega-3; Female; Hot Flashes; Humans; Menopause; Middle Aged; Sweating; Venlafaxine Hydrochloride; Yoga | 2018 |
The efficacy and tolerability of SSRI/SNRIs in the treatment of vasomotor symptoms in menopausal women: a systematic review.
Topics: Adult; Aged; Citalopram; Desvenlafaxine Succinate; Female; Fluoxetine; Hot Flashes; Humans; Menopause; Middle Aged; Paroxetine; Serotonin and Noradrenaline Reuptake Inhibitors; Sertraline; Vasomotor System; Venlafaxine Hydrochloride | 2015 |
Hormone Therapy and Other Treatments for Symptoms of Menopause.
Topics: Acupuncture Therapy; Administration, Intravaginal; Amines; Antidepressive Agents; Atrophy; Cyclohexanecarboxylic Acids; Dietary Supplements; Drug Therapy, Combination; Dyspareunia; Estrogen Replacement Therapy; Estrogens; Exercise Therapy; Female; Gabapentin; gamma-Aminobutyric Acid; Hot Flashes; Humans; Hypnosis; Indoles; Menopause; Paroxetine; Progestins; Selective Estrogen Receptor Modulators; Tamoxifen; Vagina; Vaginal Diseases; Vasomotor System; Venlafaxine Hydrochloride | 2016 |
Making sense of the evidence regarding nonhormonal treatments for hot flashes.
Topics: Acetates; Activities of Daily Living; Algorithms; Amines; Cyclohexanecarboxylic Acids; Cyclohexanols; Decision Trees; Drug Monitoring; Drug Therapy, Combination; Evidence-Based Medicine; Excitatory Amino Acid Antagonists; Female; Gabapentin; gamma-Aminobutyric Acid; Hot Flashes; Humans; Menopause; Middle Aged; Nursing Assessment; Patient Selection; Quality of Life; Selective Serotonin Reuptake Inhibitors; Self Care; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride | 2004 |
Noradrenergic and serotonergic modulation to treat vasomotor symptoms.
Topics: Citalopram; Cyclohexanols; Female; Fluoxetine; Hot Flashes; Humans; Menopause; Mianserin; Mirtazapine; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Trazodone; Venlafaxine Hydrochloride | 2006 |
4 trial(s) available for venlafaxine hydrochloride and Menopause
| Article | Year |
|---|---|
Effects of Pharmacologic and Nonpharmacologic Interventions on Insomnia Symptoms and Self-reported Sleep Quality in Women With Hot Flashes: A Pooled Analysis of Individual Participant Data From Four MsFLASH Trials.
Topics: Antidepressive Agents, Second-Generation; Citalopram; Cognitive Behavioral Therapy; Double-Blind Method; Estradiol; Exercise; Exercise Therapy; Fatty Acids, Omega-3; Female; Hot Flashes; Humans; Meditation; Menopause; Middle Aged; Outcome Assessment, Health Care; Placebos; Self Report; Sleep; Sleep Initiation and Maintenance Disorders; Venlafaxine Hydrochloride; Yoga | 2018 |
Influence of sex and menopausal status on response, remission, and recurrence in patients with recurrent major depressive disorder treated with venlafaxine extended release or fluoxetine: analysis of data from the PREVENT study.
Topics: Adult; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Double-Blind Method; Female; Fluoxetine; Humans; Male; Menopause; Middle Aged; Placebos; Proportional Hazards Models; Recurrence; Remission Induction; Selective Serotonin Reuptake Inhibitors; Sex Factors; Treatment Outcome; Venlafaxine Hydrochloride | 2014 |
Effects of estradiol and venlafaxine on insomnia symptoms and sleep quality in women with hot flashes.
Topics: Cyclohexanols; Double-Blind Method; Estradiol; Estrogens; Female; Hot Flashes; Humans; Menopause; Middle Aged; Perimenopause; Sleep; Sleep Initiation and Maintenance Disorders; Venlafaxine Hydrochloride | 2015 |
Phase III comparison of depomedroxyprogesterone acetate to venlafaxine for managing hot flashes: North Central Cancer Treatment Group Trial N99C7.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antineoplastic Agents, Hormonal; Cyclohexanols; Drug Therapy, Combination; Female; Hot Flashes; Humans; Medroxyprogesterone Acetate; Menopause; Middle Aged; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2006 |
9 other study(ies) available for venlafaxine hydrochloride and Menopause
| Article | Year |
|---|---|
Should This Patient Receive Hormone Therapy for Her Menopausal Symptoms?: Grand Rounds Discussion From Beth Israel Deaconess Medical Center.
Topics: Antidepressive Agents, Second-Generation; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Menopause; Middle Aged; Quality of Life; Risk Assessment; Sleep Wake Disorders; Venlafaxine Hydrochloride | 2018 |
Methods for the design of vasomotor symptom trials: the menopausal strategies: finding lasting answers to symptoms and health network.
Topics: Biomedical Research; Citalopram; Cyclohexanols; Dietary Supplements; Double-Blind Method; Estradiol; Estrogens; Exercise Therapy; Fatty Acids, Omega-3; Female; Hot Flashes; Humans; Menopause; Outcome Assessment, Health Care; Patient Selection; Placebos; Quality Control; Randomized Controlled Trials as Topic; Research Design; Selective Serotonin Reuptake Inhibitors; Statistics as Topic; Sweating; Time Factors; Venlafaxine Hydrochloride; Yoga | 2014 |
Ovariectomy changes the response to antidepressant drugs in tail suspension test in mice.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Depression; Disease Models, Animal; Doxepin; Estrogens; Female; Hindlimb Suspension; Menopause; Mice; Mice, Inbred ICR; Ovariectomy; Paroxetine; Venlafaxine Hydrochloride | 2016 |
Celery root extract as an inducer of mania induction in a patient on venlafaxine and St John's Wort.
Topics: Antidepressive Agents, Second-Generation; Apium; Bipolar Disorder; Depressive Disorder, Major; Female; Herb-Drug Interactions; Humans; Hypericum; Menopause; Middle Aged; Phytotherapy; Plant Preparations; Plant Roots; Psychiatric Status Rating Scales; Treatment Outcome; Venlafaxine Hydrochloride; Withholding Treatment | 2016 |
Menopausal symptoms following tamoxifen treatment for breast cancer.
Topics: Antidepressive Agents, Second-Generation; Antineoplastic Agents, Hormonal; Breast Neoplasms; Carcinoma, Ductal, Breast; Cyclohexanols; Female; Hot Flashes; Humans; Menopause; Middle Aged; Relaxation Therapy; Tamoxifen; Venlafaxine Hydrochloride | 2008 |
The multidisciplinary management of menopausal symptoms after breast cancer: a unique model of care.
Topics: Adult; Aged; Aged, 80 and over; Ambulatory Care Facilities; Amines; Anti-Anxiety Agents; Breast Neoplasms; Clonidine; Cyclohexanecarboxylic Acids; Cyclohexanols; Fatigue; Female; Gabapentin; gamma-Aminobutyric Acid; Hot Flashes; Humans; Libido; Menopause; Middle Aged; Patient Care Team; Patient Education as Topic; Patient Satisfaction; Patient-Centered Care; Practice Guidelines as Topic; Referral and Consultation; Selective Serotonin Reuptake Inhibitors; Sleep Wake Disorders; Sweating; Sympatholytics; Venlafaxine Hydrochloride; Vitamin E; Vitamins | 2010 |
Breast enlargement during chronic antidepressant therapy.
Topics: Breast; Breast Diseases; Cyclohexanols; Depressive Disorder; Female; Fluoxetine; Humans; Hyperplasia; Male; Menopause; Paroxetine; Prolactin; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride; Weight Gain | 1997 |
Nonhormonal agents show promise against hot flashes.
Topics: Antidepressive Agents, Second-Generation; Antihypertensive Agents; Clonidine; Contraindications; Controlled Clinical Trials as Topic; Cyclohexanols; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Male; Menopause; Middle Aged; Selective Serotonin Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride | 2000 |
Flushing in a menopausal woman taking venlafaxine.
Topics: Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Estrogens, Conjugated (USP); Female; Flushing; Hot Flashes; Humans; Menopause; Middle Aged; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2001 |